An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
Trial details
- Registry ID
- NCT03921528
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyNCT03921528 | Scholar Rock, Inc. | Phase 2 | Completed | 2021-01-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |